Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vignesh T Packiam

Showing results (71-80 of 136) with videos related to

Pageof 14
Sort By:
Journal of Endourology|June 25, 2016
The Impact of Perioperative Aspirin on Bleeding Complications Following Robotic Partial NephrectomyVignesh T Packiam, Charles U Nottingham, Andrew J Cohen, et al.
Urologic Oncology|April 12, 2024
Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situIan M McElree, Sarah L Mott, Helen Y Hougen, et al.
Urology|November 5, 2022
Post-procedural Antibiotic Use and Associated Outcomes After Common Urologic Procedures Across a National Healthcare SystemBibiana A R Granado, Bruce Alexander, Ryan L Steinberg, et al.
BJU International|October 22, 2025
Long-term outcomes of a cascading salvage strategy for high-risk non-muscle-invasive bladder cancerIan M McElree, Ryan L Steinberg, Helen Y Hougen, et al.
Urologic Oncology|December 1, 2022
Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancerPhani T Chevuru, Ian M McElree, Sarah L Mott, et al.
Urology Case Reports|August 30, 2023
Neoadjuvant systemic and intravesical chemotherapy with partial cystectomy for muscle invasive bladder cancer with concomitant CISBenjamin D Plambeck, Tutku E Tazegul, Ian M McElree, et al.
Urologic Oncology|July 13, 2023
Sequential intravesical gemcitabine and docetaxel for treatment-naïve and previously treated intermediate-risk nonmuscle invasive bladder cancerIan M McElree, Joanna Orzel, Reid Stubbee, et al.
The Canadian Journal of Urology|January 7, 2026
Current and perceived optimal use of point-of-care ultrasound in urologyCharles H Schlaepfer, Zubin Shetty, Vignesh T Packiam, et al.
Urologic Oncology|May 14, 2020
Simultaneous versus staged partial nephrectomies for bilateral synchronous solid renal massesVignesh T Packiam, Matvey Tsivian, Christine M Lohse, et al.
Urologic Oncology|May 1, 2023
Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysisLaura Bukavina, Spencer Bell, Vignesh T Packiam, et al.
Pageof 14

Showing results (71-80 of 136) with videos related to

Sort By:
Pageof 14
Journal of Endourology|June 25, 2016
The Impact of Perioperative Aspirin on Bleeding Complications Following Robotic Partial NephrectomyVignesh T Packiam, Charles U Nottingham, Andrew J Cohen, et al.
Urologic Oncology|April 12, 2024
Sequential endoluminal gemcitabine and docetaxel vs. Bacillus Calmette-Guérin for the treatment of upper tract carcinoma in situIan M McElree, Sarah L Mott, Helen Y Hougen, et al.
Urology|November 5, 2022
Post-procedural Antibiotic Use and Associated Outcomes After Common Urologic Procedures Across a National Healthcare SystemBibiana A R Granado, Bruce Alexander, Ryan L Steinberg, et al.
BJU International|October 22, 2025
Long-term outcomes of a cascading salvage strategy for high-risk non-muscle-invasive bladder cancerIan M McElree, Ryan L Steinberg, Helen Y Hougen, et al.
Urologic Oncology|December 1, 2022
Long-term follow-up of sequential intravesical gemcitabine and docetaxel salvage therapy for non-muscle invasive bladder cancerPhani T Chevuru, Ian M McElree, Sarah L Mott, et al.
Urology Case Reports|August 30, 2023
Neoadjuvant systemic and intravesical chemotherapy with partial cystectomy for muscle invasive bladder cancer with concomitant CISBenjamin D Plambeck, Tutku E Tazegul, Ian M McElree, et al.
Urologic Oncology|July 13, 2023
Sequential intravesical gemcitabine and docetaxel for treatment-naïve and previously treated intermediate-risk nonmuscle invasive bladder cancerIan M McElree, Joanna Orzel, Reid Stubbee, et al.
The Canadian Journal of Urology|January 7, 2026
Current and perceived optimal use of point-of-care ultrasound in urologyCharles H Schlaepfer, Zubin Shetty, Vignesh T Packiam, et al.
Urologic Oncology|May 14, 2020
Simultaneous versus staged partial nephrectomies for bilateral synchronous solid renal massesVignesh T Packiam, Matvey Tsivian, Christine M Lohse, et al.
Urologic Oncology|May 1, 2023
Sequential intravesical gemcitabine-docetaxel vs. bacillus Calmette-Guerin (BCG) in the treatment of non-muscle invasive bladder cancer: A preliminary cost-effectiveness analysisLaura Bukavina, Spencer Bell, Vignesh T Packiam, et al.
Pageof 14